Back
Denali Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
DNLI
Denali Therapeutics
Last Price:
$14.00
Seasonality Move:
1.08%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.64 | Sell |
| 20-day SMA: | 14.41 | Sell |
| 50-day SMA: | 14.26 | Sell |
| 200-day SMA: | 19.52 | Sell |
| 8-day EMA: | 12.97 | Buy |
| 20-day EMA: | 8.64 | Buy |
| 50-day EMA: | 4.41 | Buy |
| 200-day EMA: | 1.26 | Buy |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.01 | Buy |
| Relative Strength Index (14 RSI): | 45.79 | Sell |
| Chaikin Money Flow: | -1194329 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.01 - 14.83) | Sell |
| Bollinger Bands (100): | (13.09 - 16.03) | Sell |
Denali Therapeutics Technical Analysis
| Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
-
Denali Therapeutics share price is 14.00 while DNLI 8-day simple moving average is 14.64, which is a Sell signal.
-
The stock price of DNLI is 14.00 while Denali Therapeutics 20-day SMA is 14.41, which makes it a Sell.
-
Denali Therapeutics 50-day simple moving average is 14.26 while DNLI share price is 14.00, making it a Sell technically.
-
DNLI stock price is 14.00 and Denali Therapeutics 200-day simple moving average is 19.52, creating a Sell signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
23
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a SellThe current Denali Therapeutics [DNLI] share price is $14.00. The Score for DNLI is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics Stock Info
Market Cap:
2B
Price in USD:
14.00
Share Volume:
1.3M
Denali Therapeutics 52-Week Range
52-Week High:
33.33
52-Week Low:
10.57
Sell
23
Denali Therapeutics (DNLI)
is a Sell
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?The Denali Therapeutics stock price is 14.00 USD today.
-
Will DNLI stock go up or go down?Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Denali Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is overvalued.
Is Denali Therapeutics Stock a Buy?
-
Denali Therapeutics share price is 14.00 while DNLI 8-day exponential moving average is 12.97, which is a Buy signal.
-
The stock price of DNLI is 14.00 while Denali Therapeutics 20-day EMA is 8.64, which makes it a Buy.
-
Denali Therapeutics 50-day exponential moving average is 4.41 while DNLI share price is 14.00, making it a Buy technically.
-
DNLI stock price is 14.00 and Denali Therapeutics 200-day simple moving average is 1.26, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.30 per share, and an increase next year of $0.26 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
-
DNLI Moving Average Covergence Divergence (MACD) indicator is 4.01, suggesting Denali Therapeutics is a Buy
-
Denali Therapeutics Relative Strength Index (RSI) is 45.79, which suggest Denali Therapeutics is oversold
-
The Bollinger Bands (25) for Denali Therapeutics is (14.01 - 14.83), which suggest Denali Therapeutics is a Sell
-
The Bollinger Bands (100) for Denali Therapeutics is (13.09 - 16.03), which suggest Denali Therapeutics is a Sell
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.